BIOMUNEX Trademark

Trademark Overview


On Wednesday, September 23, 2015, a trademark application was filed for BIOMUNEX with the United States Patent and Trademark Office. The USPTO has given the BIOMUNEX trademark a serial number of 79177670. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Tuesday, August 29, 2023. This trademark is owned by BIOMUNEX PHARMACEUTICALS. The BIOMUNEX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations for the prevention and treatment of cancer, blood disorders and inflammatory, viral, metabolic, endocrine, oncological, ophthalmic, infectious, gynecological, cardiological, dermatological, neurological, renal, pulmonary and immune system related diseases and disorders; vaccines ]

Scientific and technical research services in the fields of vaccines, cancer and inflammatory, viral, metabolic, endocrine, oncological, ophthalmic, infectious, gynecological, cardiological, dermatological, neurological, renal, pulmonary and immune system related diseases, and in the field of pharmaceuticals for the treatment of diseases and cancer; research and development of new products for others
biomunex

General Information


Serial Number79177670
Word MarkBIOMUNEX
Filing DateWednesday, September 23, 2015
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateTuesday, August 29, 2023
Registration Number5134966
Registration DateTuesday, February 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements


Goods and Services[ Pharmaceutical preparations for the prevention and treatment of cancer, blood disorders and inflammatory, viral, metabolic, endocrine, oncological, ophthalmic, infectious, gynecological, cardiological, dermatological, neurological, renal, pulmonary and immune system related diseases and disorders; vaccines ]
Goods and ServicesScientific and technical research services in the fields of vaccines, cancer and inflammatory, viral, metabolic, endocrine, oncological, ophthalmic, infectious, gynecological, cardiological, dermatological, neurological, renal, pulmonary and immune system related diseases, and in the field of pharmaceuticals for the treatment of diseases and cancer; research and development of new products for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, August 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 7, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOMUNEX PHARMACEUTICALS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPARIS F-75116
FR

Party NameBIOMUNEX PHARMACEUTICALS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameBIOMUNEX PHARMACEUTICALS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, January 14, 2016REFUSAL PROCESSED BY MPU
Thursday, December 3, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, December 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 11, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, January 12, 2016ASSIGNED TO EXAMINER
Tuesday, January 12, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 13, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 27, 2016FINAL REFUSAL E-MAILED
Thursday, January 14, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 1, 2016REFUSAL PROCESSED BY IB
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 12, 2016ASSIGNED TO LIE
Wednesday, July 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 27, 2016FINAL REFUSAL WRITTEN
Wednesday, July 27, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 12, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 18, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sunday, May 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 5, 2017FINAL DISPOSITION PROCESSED
Monday, June 5, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 23, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, February 7, 2023TEAS SECTION 71 RECEIVED
Tuesday, August 29, 2023NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, August 29, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 29, 2023REGISTERED - PARTIAL SEC 71 ACCEPTED
Monday, April 29, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, June 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Sunday, June 2, 2024PARTIAL INVALIDATION PROCESSED BY THE IB
Tuesday, May 7, 2024INVALIDATION PROCESSED
Wednesday, May 8, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB